Published in Gut on June 20, 2014
Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. Gastroenterology (2016) 1.52
Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer. Clin Cancer Res (2015) 1.46
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer. PLoS One (2017) 1.39
TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res (2015) 1.14
Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy That Cotargets MEK and CDK4/6. Clin Cancer Res (2015) 0.84
Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity. Oncotarget (2016) 0.83
Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels. Oncotarget (2015) 0.82
MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2. Oncotarget (2016) 0.82
Advances in targeted and immunobased therapies for colorectal cancer in the genomic era. Onco Targets Ther (2016) 0.81
Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics. Oncotarget (2015) 0.80
Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression. Sci Rep (2016) 0.77
Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer. PLoS Genet (2016) 0.77
Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells. Cancer Biol Ther (2016) 0.76
5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1/β-catenin/MMP-7 signaling pathway. Oncotarget (2015) 0.76
Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer. Oncogene (2015) 0.76
NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing. Oncotarget (2016) 0.76
Molecular predictive markers in tumors of the gastrointestinal tract. World J Gastrointest Oncol (2016) 0.75
Molecular Testing for Gastrointestinal Cancer. J Pathol Transl Med (2017) 0.75
A novel TP53 pathway influences the HGS-mediated exosome formation in colorectal cancer. Sci Rep (2016) 0.75
DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells. Leukemia (2016) 0.75
Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway. Cell Death Dis (2017) 0.75
Revealing Genomic Profile That Underlies Tropism of Myeloma Cells Using Whole Exome Sequencing. Int J Genomics (2015) 0.75
History and progression of Fat cadherins in health and disease. Onco Targets Ther (2016) 0.75
DOCK2 confers immunity and intestinal colonization resistance to Citrobacter rodentium infection. Sci Rep (2016) 0.75
Differential analysis between somatic mutation and germline variation profiles reveals cancer-related genes. Genome Med (2017) 0.75
Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing. Front Pharmacol (2017) 0.75
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
Global cancer statistics. CA Cancer J Clin (2011) 185.92
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res (2010) 97.51
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res (2010) 43.51
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (1997) 24.61
Comprehensive genomic characterization of squamous cell lung cancers. Nature (2012) 18.90
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13
VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90
Diverse somatic mutation patterns and pathway alterations in human cancers. Nature (2010) 10.83
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol (2004) 7.16
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol (2005) 5.13
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet (2012) 4.82
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet (2011) 3.10
Functional impact bias reveals cancer drivers. Nucleic Acids Res (2012) 2.96
ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell (2013) 2.32
SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway. Proc Natl Acad Sci U S A (2001) 1.65
Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev (2008) 1.56
Identification of Fat4 as a candidate tumor suppressor gene in breast cancers. Int J Cancer (2009) 1.49
A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells. Oncogene (2011) 1.49
The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics (1994) 1.46
Identification of three human type-II classic cadherins and frequent heterophilic interactions between different subclasses of type-II classic cadherins. Biochem J (2000) 1.41
Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol (2012) 1.37
DNA methylation biomarkers for lung cancer. Tumour Biol (2011) 1.35
Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol (2011) 1.32
Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. Cancer Res (2005) 1.30
Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancer. PLoS One (2011) 1.19
Recognition of DNA alterations by the mismatch repair system. Biochem J (1999) 1.08
Signal transduction by the Fat cytoplasmic domain. Development (2013) 1.07
Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis. Crit Rev Oncol Hematol (2012) 0.97
Genome-wide association and sequencing studies on colorectal cancer. Semin Cancer Biol (2013) 0.83
The intercellular adhesion molecule, cadherin-10, is a marker for human prostate luminal epithelial cells that is not expressed in prostate cancer. Mod Pathol (2007) 0.81
Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway. Oncotarget (2014) 0.87
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma. Cancer (2017) 0.75